文献速递骨肌PETCTMR

FDG PET在肉瘤分子影像中的应用

Molecular imaging of sarcomas with FDG PET.
PubMed 文献 · Skeletal Radiol · 2022-09-29

本文综述了FDG PET/CT在骨肉瘤、软骨肉瘤、尤文肉瘤和横纹肌肉瘤等肉瘤管理中的应用价值,指出FDG PET在鉴别良恶性病变、分期和再分期方面具有优势,但在预后预测和治疗反应评估方面的数据有限,并讨论了其局限性和未满足的需求。

要点

  • FDG PET可辅助鉴别肉瘤的良恶性病变。
  • FDG PET在肉瘤分期和再分期中具有价值。
  • FDG PET在预后预测和治疗反应评估中的数据有限。

核心结论

  • FDG PET/CT作为代谢成像,可补充并提供优于其他单独成像模式的诊断信息,尤其在鉴别良恶性病变、分期和再分期方面有优势。
  • FDG PET在肉瘤预后预测和治疗反应评估方面的数据有限。

研究设计与样本

  • 本文为综述,聚焦FDG PET在骨肉瘤、软骨肉瘤、尤文肉瘤和横纹肌肉瘤的初始病变范围评估、治疗反应和监测成像中的作用。
  • 文章讨论了FDG PET的要点和陷阱,以及其在肉瘤管理中的局限性和未满足的需求。

临床应用与阅片要点

  • FDG PET/CT可补充CT和MRI,提供代谢信息,辅助肉瘤的诊断和分期。
  • 在肉瘤的初始分期、治疗反应评估和监测中可考虑使用FDG PET,但需注意其预后预测价值有限。

局限性

  • FDG PET在肉瘤预后预测和治疗反应评估方面的数据有限。
  • 文章讨论了FDG PET在肉瘤管理中的局限性和未满足的需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Sarcoma comprises a heterogenous entity of musculoskeletal malignancies arising from a mesenchymal origin. The diagnosis and management of pediatric sarcoma requires a multidisciplinary approach and the use of various imaging modalities including CT, MRI and FDG PET scans. FDG PET/CT (FDG PET), as a metabolic imaging, complements and provides superior diagnostic information as against other imaging modalities alone. Advantages of FDG PET in differentiating malignant sarcomatous lesions from benign lesions, and value in staging and restaging have been noted in several studies. The use of FDG PET in clinical management has increased over the years. The data on prognostication of outcomes or predicting responders to therapy with FDG PET in patients with sarcoma is somewhat limited. This review will focus on the pearls and pitfalls of FDG PET and role of FDG PET in initial extent of disease assessment, treatment response, and surveillance imaging pertaining to osteosarcoma, chondrosarcoma, Ewing's sarcoma, and rhabdomyosarcoma. We also discuss the limitations and unmet needs of FDG PET in the management of patients with sarcoma.

来源:Skeletal Radiol,查看原文。版权归原作者所有。

引用

  1. Mendoza, Nosov, Pandit-Taskar, et al. Molecular imaging of sarcomas with FDG PET. Skeletal Radiol. 2022. PMID: 36173459. doi:10.1007/s00256-022-04182-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。